Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$282.99 - $369.05 $350,624 - $457,252
-1,239 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$259.0 - $414.71 $7,511 - $12,026
29 Added 2.4%
1,239 $429,000
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $24,780 - $29,032
-102 Reduced 7.77%
1,210 $338,000
Q4 2020

Feb 08, 2021

BUY
$236.26 - $355.63 $16,301 - $24,538
69 Added 5.55%
1,312 $321,000
Q3 2020

Nov 04, 2020

BUY
$264.77 - $305.71 $10,061 - $11,616
38 Added 3.15%
1,243 $353,000
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $180,027 - $238,414
-696 Reduced 36.61%
1,205 $322,000
Q1 2020

May 05, 2020

BUY
$268.85 - $341.04 $216,155 - $274,196
804 Added 73.29%
1,901 $601,000
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $241,405 - $333,564
1,097 New
1,097 $326,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $8.5 Million - $10.8 Million
-30,522 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $53,125 - $69,473
-181 Reduced 0.59%
30,522 $10.8 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $158,889 - $189,363
-617 Reduced 1.97%
30,703 $8.91 Million
Q1 2018

Jun 26, 2018

SELL
$260.13 - $367.91 $125,642 - $177,700
-483 Reduced 1.52%
31,320 $8.58 Million
Q1 2018

Jun 22, 2018

BUY
$260.13 - $367.91 $125,642 - $177,700
483 Added 1.54%
31,803 $10.1 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $125,642 - $177,700
-483 Reduced 1.52%
31,320 $8.58 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $9.78 Million - $11 Million
31,803
31,803 $10.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Avalon Investment & Advisory Portfolio

Follow Avalon Investment & Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.